Tibulizumab is a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.

货号（Catalog No.）icon

CS00523

通用名INNicon

Tibulizumab

纯度(Purity)icon

>95%

浓度( Concentration)icon

1mg/ml

Formulationicon

PBS buffer pH7.5

Sourceicon

CHO cells

内毒素(Endotoxin level)icon

Please contact with the lab for this information.

产品描述(Description)icon

Tibulizumab is a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.

别名(Alternative names)icon

LY 3090106,LY-3090106,LY3090106

靶点;物种(Specificity target name;species)icon

IL17A/TNFSF13B/CD257[Homo sapiens]

种类(Species)icon

Humanized

受体鉴定(Receptor identification)icon

IgG4-kappa-[scFv]2